This promotional content has been developed, organised and funded by Pfizer Ltd and is intended for qualified UK healthcare professionals only.
Xeljanz® (tofacitinib citrate) Prescribing Information is available here
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in Google Play or Apple App Store. Adverse events should also be reported to Pfizer Medical Information on 01304 616161
The use of Xeljanz in UC: A consultant perspective
A talking head video of Gastroenterology Consultant Dr Alissa Walsh talking about her experience of prescribing Xeljanz (tofacitinib citrate) at the John Radcliffe Hospital, Oxford
The use of Xeljanz in UC: A nurse perspective
A talking head video of Lead Inflammatory Bowel Disease Nurse, Aileen Fraser talking about her experience of the use of Xeljanz (tofacitinib citrate) at Bristol Royal Infirmary
To find out more, or to watch more videos from our experts, please visit PfizerPro >>
PP-XEL-GBR-4592| June 2023
